Wed, Apr 17, 2024
Jubilant Pharmova, a wholly-owned subsidiary of the company, has received a communication from the US Food and Drug Administration (USFDA) that the facility has been classified as VAI pursuant to inspection from January 25 to February 2, 2024, it said in a regulatory filing.
More >
Wed, Dec 28, 2022
Jubilant Pharmova share price: The report, however, said that the company's generic business could face headwinds on steep pricing pressure.
Wed, Oct 20, 2021
Rekha Jhunjhunwala, the wife of Rakesh Jhunjhunwala, has raised stake in Jubilant Pharmova Ltd, showed shareholding for the period ended September 30, 2021, on the BSE.
Mon, Jun 14, 2021
In a conversation with Zee Business Managing Editor Anil Singhvi, Omkara Capital Founder Varinder Bansal decodes why Jubilant Pharmova, a company from the pharma space, is lucrative for investors and expects the company to grow rapidly in the coming year amid a strong business profile.
Mon, Apr 19, 2021
Due to the covid-19 pandemic, the pharma sector has been the most to benefit. In this regard, Jubilant Pharmova has spurted over seven per cent amid the development of a novel oral formulation of Remdesivir.
Tue, Mar 30, 2021
ICICI Securities remain positive on the pharmaceutical sector considering high possibility of growth revival in India formulations on low base of FY21, stable pricing in US generics and sustenance of cost control initiatives seen during FY21 due to pandemic, albeit partially over long term.
Fri, Sep 30, 2016
The shares of Jubilant Life Sciences surged over 2% after the company announced the issuance of bonds.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
